Maxacalcitol - Misplaced Pages

Chemical compound

Pharmaceutical compound

Maxacalcitol
Clinical data

Trade names	Oxarol
Other names	22-Oxacalcitriol; OCT
Routes of administration	IV or topical
Legal status
Legal status	In general: ℞ (Prescription only)
Identifiers
IUPAC name (1R,3S,5Z)-5--7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
CAS Number	103909-75-7
PubChem CID	6398761
IUPHAR/BPS	2784
DrugBank	DB06272
ChemSpider	4911262
UNII	N2UJM5NBF6
ChEBI	CHEBI:31801
ChEMBL	ChEMBL333950
CompTox Dashboard (EPA)	DTXSID4048648
ECHA InfoCard	100.212.050
Chemical and physical data
Formula	C₂₆H₄₂O₄
Molar mass	418.618 g·mol
3D model (JSmol)	Interactive image
SMILES C(1CC\21(CCC/C2=C\C=C/3\C(C(C3=C)O)O)C)OCCC(C)(C)O
InChI InChI=1S/C26H42O4/c1-17-20(15-21(27)16-24(17)28)9-8-19-7-6-12-26(5)22(10-11-23(19)26)18(2)30-14-13-25(3,4)29/h8-9,18,21-24,27-29H,1,6-7,10-16H2,2-5H3/b19-8+,20-9-/t18-,21+,22+,23-,24-,26+/m0/s1 Key:DTXXSJZBSTYZKE-ZDQKKZTESA-N

Maxacalcitol (trade name Oxarol) is a vitamin D₃ analog and vitamin D receptor activator (VDRA). As a pharmaceutical drug, it is used as an injection to treat secondary hyperparathyroidism resulting from hemodialysis and as a topical ointment for psoriasis.

It was approved for use in Japan in 2010 and in Taiwan in 2018.

References

Mizobuchi M, Ogata H (March 2014). "Clinical uses of 22-oxacalcitriol". Current Vascular Pharmacology. 12 (2): 324–328. doi:10.2174/15701611113119990023. PMID 23713875.
"Maxacalcitol". Inxight Drugs. National Center for Advancing Translational Sciences, U.S. National Institutes of Health.
"Maxacalcitol". New Drug Approvals in Japan. Kyoto Encyclopedia of Genes and Genomes. D01098.
Fukazawa-Shinotsuka M, Saito T, Abe M, Iida S, Wang IT, Terao K, et al. (January 2022). "Maxacalcitol Pharmacokinetic-Pharmacodynamic Modeling and Simulation for Secondary Hyperparathyroidism in Patients Receiving Maintenance Hemodialysis". Drug Research. 72 (1): 23–33. doi:10.1055/a-1581-7609. PMID 34488237.

v t e Vitamin D receptor modulators
VDRTooltip Vitamin D receptor	Agonists: 7-Dehydrocholesterol 25-Hydroxyergocalciferol Alfacalcidol Calcifediol Calciferol Calcipotriol Calcitriol Cholecalciferol (vitamin D₃) Dihydrotachysterol Doxercalciferol EB-1089 Eldecalcitol Ercalcidiol Ercalcitriol Ergocalciferol (vitamin D₂) Lithocholic acid Maxacalcitol Paricalcitol Tacalcitol Antagonists: ZK159222 TEI-9647
See also Receptor/signaling modulators

VDRTooltip Vitamin D receptor

This dermatologic drug article is a stub. You can help Misplaced Pages by expanding it.